Journal of Diabetes
Effectiveness and Safety of Fixed-Dose Combination Metformin and Empagliflozin in Type 2 Diabetes: A Prospective, Multicenter, Real-World Study From China
Cohort study of 2,602 peopleType 2 diabetes
Papers by Xuefeng Li
2 results
- International Immunopharmacology
Targeting the AKT2-NAMPT phosphorylation axis prevents macrophage senescence to enhance bactericidal activity in septic immunosuppression
Experiments in cellsInterventions